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THE principal object of studies of the cell population kinetics of tumours is to
explain how a tumour attains its particular growth rate, and thus to make a more
informed judgement on methods ofgrowth control. The growth rates of tumours
show wide variations, both between and within individual species. In man,
volume doubling times for primary and secondary lung tumours range from about
two weeks to many months (Steel and Lamerton, 1966); in experimental animals,
spontaneous tumours with volume doubling times of a few days are common and
under repeated transplantation doubling times of less than 24 hours can be
attained. The problem is to identify the proliferative characteristics of the cell
populations which have such widely different growth rates.
Such a problem must necessarily be treated as one of comparative biology.
Our ultimate aim is an understanding of the growth rate of tumours in man, but
the limitations imposed by experiments on human beings rule out at present a
thorough analysis of the cell population kinetics of human tumours. The scope
for experiment on animal tumours, particularly transplanted tumours, is much
greater. What must be done therefore, is to look first at the simplified cases
provided by experimental tumours, and then to extend the investigations to
tumours that are progressively closer to the human counterpart.
The approach in the present work has been to analyse by a variety oftechniques
the cell population kinetics of tumours of known growth rate, in order to find the
extent ofagreement between them and to characterise, as far as possible, the state
of proliferation of the tumour cell population. A similar approach has been used
by Mendelsohn (1965). Great importance is attached to the simultaneous
measurement ofvolume doubling time, for whether measurements of cell prolifera-
tion are consistent with the overall tumour growth rate is the conclusive test of
their significance.
The growth rate of a tumour is the resultant of cell production and cell loss
(Fig. 1). Cell loss is an extremely difficult parameter to measure (Steel, 1966) and
there are at present no direct methods by which it can be estimated; cell loss
would, however, be indicated by a discrepancy between total cell production rate
and overall growth rate. The state of cell proliferation in a tumour is best
specified by a distribution of cell cycle times, this being taken to include both the
distribution for proliferating cells as well as information on the fraction of cells
which are essentially non-proliferating. The distribution of cell cycle times may
or may not take a standard mathematical form. In the more heterogeneous
tumours, the fact that the availability of nutrients to different regions may vary
widely, some regions showing various degrees of starvation, suggests that aCELL POPULATION KINETICS
considerable proportion of cells may be found to have very long cycle times and
many may not divide again in the untreated tumour. The problem ofdetermining
the shape ofthe cycle time distribution is thus a difficult one, especially as regards
the measurement of the longer cycle times in the cell population.
In the face ofthis situation our approach has been to seek a model, a simplifica-
tion of the true state of affairs, which can simulate the kinetics of a tumour cell
populatioin. We have chosen a model consisting of two compartments: a
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FIG. 1. Tumour growth rate depends on three main factors: (i) the cycle time distribution
ofproliferating cells, (ii) the proportion of non-proliferating cells (iii) the extent of cell loss.
proliferative compartment in which the spread ofcell cycle time is given a standard
mathematical form and a non-proliferative compartment to which a defined
proportion of the cells produced at mitosis are continuously being added. Such a
model must be tested against the results oftechniques that are sensitive to spread
in cell cycle time. Two ofthese have been used in the present work: the technique
of labelled mitoses (Quastler and Sherman, 1959) was chosen as the starting point
since it is extremely sensitive to spread and since it also gives information about
the individual phases ofthe cell cycle. When a distribution of cell cycle times has
been found which simulates the damping of the labelled mitoses curve then
this is tested against data from a continuous labelling experiment to determine
the Proliferative Fraction and the degree of cell loss which the model should
include in order to be consistent with the data.
Experimental Methods
Tumours were maintained by subcutaneous transplantation in the same
strain and sex of rat; pieces of well-vascularised tumour, 5-10 mg. in size were
inserted using a trochar technique, with sterile precautions. Normally one
34
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implant was made into each recipient, but for the thymidine experiments two or
four implants were used, inserted through a single dorsal incision. The use of
multiple implants gave tumours which were almost as independent as ifthey were
in separate animals, as judged by variability in the growth curves; this enabled
animals and thymidine to be conserved and allowed the acceptance limits on the
size oftumours at the start ofthe experiment to be set closer than would otherwise
have been the case. It should be emphasised, however, that no attempt was
made to remove the tumours at different times from the same animal, on the
grounds that an operative procedure might influence the growth rate of the
remaining tumours.
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FIG. 2. Growth curves for the BICR/M1 tumour in its 1st, 2nd, 3rd, 4th and 143rd
transplants. The date of transplantation is given in each case.
Tumour specimens were fixed in neutral formol saline, sectioned in paraffin
at 4,', stained using the Feulgen reaction, and autoradiographed by the dipping
technique (Lord, 1963) using Ilford K5 liquid emulsion. A final Light Green
counterstain was usually employed. Tritiated thymidine (Radiochemical Centre,
U.K., TRK 61, specific activity in excess of 10 c/mM) wasinjectedintraperitoneally
at a dose of 50 ,tc to animals which weighed 100-130 g. The autoradiographic
exposure time was 4 weeks.
Choice ofExperimental Tumours
There is a dilemma in the choice of experimental tumours in that whilst early
transplants show the least deviation from the spontaneous state, their properties
are not stable. Tumour morphology, growth rate and other characteristics may
deviate during successive transplantation (Fig. 2), making it difficult to compare
786CELL POPULATION KINETICS
the results of experiments performed at different times. A well-established
tumour may show the most reproducible behaviour from one transplant to the
next, but this property is associated with considerable departure from its original
characteristics. In the present work two tumours have been used. They were
chosen on account of their wide differences in growth rate and in the number of
transplants which they had undergone.
BICR/M I
This tumour arose as a spontaneous mammary tumour in a Marshall female rat
in 1955 and at the time of the present investigation it had undergone over 150
transplantations. The tumours were round, soft and friable; histologically they
were undifferentiated and well-circumscribed, containing uniform rounded cells.
Blood vessels were small and difficult to detect, but up to a size of 1 0 g. regions of
necrosis were seldom observed. In an attempt to detect metastatic spread, 12
tumours ranging in size from 0.015 to 2 g. were excised and the animals were left
for a period of 17 weeks. No evidence of metastasis was found on subsequent
dissectioni.
BICR/A2
This tumour was a fibrosarcoma which arose in an August female rat in March
1965. In its third transplant the tumour grew with a volume doubling time of 13
days and the present work was performed on 60 animals which received a total of
140 transplants from one such donor. The tumours were round and firm, and the
histological appearance was marked by nuclei which were rather pleomorphic
anid separated by a large amount of intercellular substance.
Overall Growth Rate
(Calibration curve technique
Estimates oftumour size were obtained by external measurement using vernier
calipers, the animals being lightly anaesthetised. Whilst the caliper technique
has been used in many investigations of tumour growth, procedures for plotting
the data have varied greatly. These have included plots of greatest diameter
(Mayneord, 1932) mean diameter (Brues, Weiner and Andervont, 1939; Shreck,
1935) tumour area (Mottram, 1935) and the product of three dimensions (Hunter,
1955). For any attempt to relate cell proliferation and growth rate, tumour
volume is the important parameter; methods of determining volume from linear
measurements have included the use ofvarious theoretical equations (Blum, 1943;
McCredie, Inch, Kruuv and Watson, 1965). However, any such theoretical
approach contains some degree of uncertainty, especially as regards the need to
correct for skin thickness. There are great advantages therefore in a purely
experimental approach: to use external measurements merely for the comparison
of tumour sizes and to calibrate these in a separate experiment.
In the present work, caliper measurements were made of the greatest and
smallest superficial dimensions and the product of these was termed " tumour
area " (actually the area of the rectangle enclosing the tumour). A batch of
40 BIC)R/M1 tumours was implanted, two per animal, and these were taken in
groups at selected times during growth. Tumour area was determined on the
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anaesthetised animal and recorded. The animal was then killed and its tumours
removed and weighed on a torsion balance. The calibration curve (Fig. 3)
could then be constructed and used to interpret any measurements oftumour area
for this particular tumour. Provided the tumour does not change its average
shape or growth characteristics, this technique is free from systematic errors.
Tumour weight is obtained directly and the precision of measurement can be
judged from the scatter of experimental points about the calibration curve.
Although this is not relevant to the actual determination of a tumour growth
curve, it is interesting to note the extent to which the calibration curve conforms
to a two-thirds power law. One would obtain such a mathematical relationship
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FIG. 3.-Calibration curve for the measurement of tumour volume in the BICR/MI1 tumotur.
for measurement of the " tumour area " of a set of spherical bodies not overlaid
by skin. In Fig. 4 the calibration data are plotted on double-logarithmic scales
and a two-thirds power law has been fitted to the upper part of the curve. The
broken curve is derived from this, on the assumption of 1-5 mm. double skin
thickness on each dimension; the fact that this is consistent with the experimental
data implies that the BICR/Ml calibration curve can also be used to interpret
measurements on other tumours, provided the skin thickness is the same and the
tumour geometry is no more irregular.
Growth rate ofBICR/M1 tumours
Measurements of tumour size have been made throughout the history of this
tumour by one observer (K.A.). Only in the last two years, however, has the
calibration technique for calculating tumour weight been developed in this
laboratory; it has therefore been necessary to use a calibration curve obtained
during this period to interpret measurements made earlier.
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The data (Fig. 2) show that in the first transplant the tumours reached a size
of 1 g. at 56 days after implantation and then grew first with a volume doubling
time of 5 days and later of 12 days. Subsequent transplants grew progressively
faster. The second transplantation was into 4 females and 2 males. The growth
curves in these two cases are barely distinguishable, showing nearly exponential
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FiG. 4.-Calibration curve data of Fig. 3, plotted on double-logarithmic scales. The full
line is a two-thirds power law; the broken line is derived from this assuming 1-5 mm.
double skin-thickness on each superficial dimension.
growth with a doubling time of about 5 days. The striking characteristic of the
3rd and 4th transplants is that in these cases the growth curves are unmistakably
concave upwards on the semi-logarithmic plot. This is an unusual observation;
as a general rule, tumour growth curves are convex upwards (Laird, 1964), the
specific growth rate decreasing with time. The significance of the observation
presumably lies in the process by which, as a result of the " natural selection " of
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cells with the highest potentiality for growth, the tumour adapts to growth in the
host. In these two cases, it would seem that adaptation was observed during the
growth of the individual transplants. By the 4th transplant, the minimum
doubling time achieved was approximately 3 days.
A typical growth curve for the BICR/Ml tumour during the course of the
present investigations isshown inFig. 5. Tumours were chosenwhentheyreached
7 mm. diameter (0.1 g.), a sufficient size to obtain accurate volume measurements,
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FIG. 5. Growth curves for the two tumours. Tumour weight is obtained from
superficial measurements using the calibration curve of Fig. 3.
and the investigations were usually complete by the time the tumours reached a
size of 1 g. Over this size range, growth was almost exponential. The mean
doubling time measured at a size of 0 5 g. in 7 successive transplants (6 tumours
in each transplant) was 22-7 ± 2-5 hours.
Growth rate ofBICR/A2 tumours
Because ofthe similarity ofthe two tumours as regards size and shape, and the
similarskinthickness ofAugust andMarshall rats, the calibration curvedetermined
for the MI tumour was used to interpret measurements on the A2 also. The
resulting growth curve for 10 tumours implanted at the same time as those used
for thymidine studies is shown in Fig. 5. In the size range 0 1to 10 g. the volume
doubling time was 7-9 days (190 hours).
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Results of H3-Thymidine Experiments
Three types of investigation were carried out using tritiated thymidine. The
data obtained from these provide the basis of the analysis in the section that
follows.
Thymidine labelling index
The proportions of cells found to be labelled one hour after tritiated thymidine
injection were as follows:
BICR/M1-34-2 + 4-4%, determined on six tumours whose weights were in
the range 0-09 to 1-07 g.
BICR/A2-3-5 ± 1-8%, determined on six tumours in the weight range 0-17
to 1P4g.
Percentage labelled mitoses experiment.
The labelled mitoses technique has been widely used in cell population kinetics
since its introduction by Quastler and Sherman (1959). Published labelled mitoses
curves on tumours have included those of Mendelsohn, Dohan and Moore (1960),
Kim and Evans (1964), Johnson (1961).
For the present investigations thymidine was injected either in the morning
or late afternoon, for convenience in the time ofkilling. The existence of diurnal
variations in mitotic index was not investigated, but would seem unlikely on the
basis of published work on other transplanted tumours (Bertalanffy and McAskil,
1964a, 1964b). Autoradiographs were examined under oil-immersion objective
(magnification x 1000) and only reliable metaphases and anaphases were counted.
The results on the BICR/M1 and A2 tumours are shown in Fig. 6 and 7. In
experiments where the kinetics of cell proliferation are studied at intervals after
a dose of tritiated thymidine, there is always the possibility of artefacts arising
from radiation effects of the tritium label. This possibility was examined in the
following way. By inspection of the labelled mitoses curve for the BICR/M1
tumour (Fig. 6), the steepest point in the second rise is seen to occur at 19-5 hours
after injection. If any change in the timing of the cell cycle is induced, one
might expect the greatest effect to be seen at this point. Fifteen animals, each
bearing two MI tumours were divided randomly into five groups ofthree, in which
they received doses of thymidine ranging from 0-25 ,uc/g. to 5 0 ,ac/g. The
animals were injected within a period of 20 minutes and were all killed at exactly
19-5 hours after injection. In order to avoid bias during the scoring of the
autoradiographs these were exposed for periods which were inversely proportional
to the dose received, ranging from 3 days to 8 weeks. The results are shown in
Table I. There was no significant trend in the results even when the dose was
raised by a factor of ten above that used for the labelled mitoses investigation.
TABLE I.-Dose-Response of Percentage of Labelled Mitoses
Observed 19-5 Hours After Injection (BICR/M1 Tumour)
Dose /uc/g.* No. of tumours Mean % Standard error of mean
0-25 8 36-6 2-7
0-5 6 41-1 4-4
1-0 4 45-5 3-0
2-0 6 35-5 3-3
5-0 4 49-0 3-8
* Dose used for labelled mitoses curve was about 0-45 yuc/g.
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FIG. 6.-Labelled mitoses and continuous labelling data for the BICR/M1 tumour. The curve
shown in the upper diagram was computed using the parameters given in Table II. In the
lower diagram, the full curve is calculated for Model B assuming 5% non-proliferating cells.
Continuous labelling experiment
Continuous thymidine labelling has been used by a number of investigators
to obtain quantitative information. Mendelsohn (1962b) employed this technique
in his studies of cell proliferation in C3H mouse mammary tumours; both he
and Lobbecke, Schultze and Maurer (1966, personal communication) have used
continuous thymidine infusion from an external pump. Baserga, Kisieleski
and Halvorsen (1960) used repeated thymidine injections at intervals less than
the length of the DNA synthetic period to label Ehrlich ascites cells growing in
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FIG. 7.-Labelled mitoses and continuous labelling data for the BICR/A2 tumour. The curve
shown in the upper diagram was computed using the parameters given in Table II. In the
lower diagram curve (a) is calculated forModel B and curves (b) an4d (c) forModel C, assuming
a Q-cell life-span of 285 and 190 hours respectively.
the lungs of mice. Kim and Evans (1964), also using the Ehrlich tumour but in
the ascitic form, used a technique in which thymidine was injected at hourly
intervals. The analysis of continuous labelling data has been discussed by
Wimber (1963).
In the present work, thymidine was given by intraperitoneal injection every
6 hours (every 4 hours for the first 12 hours in the case of BICR/Mi) the first
injection being given at 12*00 midday. Of the two tumours used here, BICR/Ml
has the shorter DNA synthetic period (8.0 ± 1-5 hours) and for this the use of
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6-hourly injections ensures that at least 9900 of cells entering synthesis are
labelled (ofeach 6-hour cohort, about 170 are within the 1-hour period just before
synthesis at the time of each injection, and of these only about 5% have a short
enough S-period to complete synthesis before the next injection). The results
of the continuous labelling experiments are shown in Fig. 6 and 7.
Method of Analysis of Tumour Cell Kinetics
The analysis has been made by considering theoretical models of increasing
complexity, in order to find the simplest that will fit the experimental data. Three
models have been considered, all of which are based on exponential growth.
(The terminology of Cairnie, Lamerton and Steel, (1965) will be used, " P-cells "
signifying proliferating cells and " Q-cells " those that will not, in the untreated
tumour, divide again):
Model A: All cells proliferate, the cycle time distribution being that which is
found to satisfy the percentage labelled mitoses data (see below).
There is no cell loss.
Model B: Both P- and Q-cells are present. The cycle time distribution of
P-cells is as in Model A; Q-cells have an unlimited life-span. Q-cells
are produced with a constant probability at every division, and there
is no cell loss.
Model C: As for Model B, except that one of three possible types of cell loss is
included:
(i) by Q-cells having a limited life-span, after which they are removed
from the population.
(ii) by cell loss at mitosis.
(iii) by random loss of cells at any stage from both the P- and Q-cell
compartments.
Analysis of the labelled mitoses data.
The method of analysis of the labelled mitoses data to obtain information
about spread in cell cycle time has already been described (Barrett, 1966b).
In outline, this was as follows:
(i) the type of distribution for the times spent separately in G1, S and G2 was
selected; for the present work independent log-normal distributions were
chosen.
(ii) by inspection of the data, approximate values of the mean and standard
deviation of each of the phases G1, S and G2 were obtained (six
parameters) ; for this purpose the time of mitosis was regarded as being
equally divided between G1 and G2.
(iii) A Monte Carlo method of computation was used on the University of
London " Atlas " computer. A series of 2000 random values for time
spent in G2 was generated, distributed according to the chosen distribution
and similarly for the times spent in S and G1.
(iv) the technique of computation was then essentially to take each ofthe 2000
mitotic figures in turn, to choose values for G2, S and G1 and record the
times at which a mitotic cell or any of its ancestors was previously in
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DNA synthesis. Time intervals ofone hour were used in order to simulate
the fact that the " window " of mitosis is approximately of this width.
Finally a process of summation enabled the percentage oflabelled mitoses
to be plotted as a function of the time separating injection and sampling.
(v) the theoretical curve was then compared with the experimental data and
adjustments made as necessary to the six parameters until recalculation
showed a satisfactory fit.
The values of the six parameters obtained for each tumour are shown in Table II.
Fig. 8 shows the distributions of cell cycle time which apply in each case.
TABLE II.-Kinetic Parameters of the Cell Cycle
and Growth Rate of the Two Tumours
BICR/MI BICR/A2
F -1
mean S.D. mean S.D.
Gl . 8.0 4-2 . 50 40
S 8-0 1.5 10 3
G2 . 30 1 6 3 1
Whole cycle 19-0 4-7 63 40
Doubling time . 227 2.5* . 190 t
* S.D. of measured growth rate in 42 transplants (see text).
t possible error of +25 hours.
Two points should be noted about the above analysis. Firstly, the cell cycle
time distributions shown in Fig. 8 are distributions for cells seen in mitosis and
not for a random sample of cells taken from the tumour at any one time. In
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FIG. 8. Distribution of cell cycle time for the two tumours, obtained using the
parameters given in Table II.
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Quastler's terminology (Quastler, 1963) this is therefore a " flux " rather than a
" compartment" distribution, by comparison with which it is weighted towards
those cells which have short cycle times. Throughout the present work it is,
however, a flux distribution which is required.
Secondly, the calculations are based on the choice of log-normal distributions
of phase duration (the corresponding distribution of cell cycle times is not log-
normal but somewhat less skew). The accuracy of the experimental data does
not allow one to check the suitability of this choice with any great precision.
In particular, since the technique of labelled mitoses is relatively insensitive to
cells with long cycle times it is possible that the true cycle time distribution has a
longer " tail " than the theoretical one. Accordingly the present analysis is
based on the three models described above: our hypothesis is that such models
can be found which will simulate the tumour with respect to the techniques used
in the present investigation and which may well simulate its response to other
types of investigation also. We define P-cells to have a specified distribution of
cycle times (as shown in Fig. 8) and will refer to their proportion of the whole as
the " Proliferative Fraction " (p), analogous to Mendelsohn's " Growth Fraction "
(Mendelsohn, 1962a) but renamed to emphasise that it is a theoretical concept
based on these particular models.
Age distribution diagrams.
In order to relate the distribution ofcell cycle time found above to the labelling
index and continuous labelling data, it is useful to employ the age distribution
diagram (Johnson, 1961 ; Cairnie, Lamerton and Steel, 1965; Barrett, 1966a,
1966b). Such a diagram indicates the probability offinding a cell at any point in
the cell cycle and in the case of tumours it is useful to extend the concept, as
shown in Fig. 9, to indicate also the age distribution of Q-cells. This diagram
is drawn for a model in which there is exponential growth with no spread in cell
cycle time and no cell loss. Of each pair of cells produced at division of remain in
the proliferative compartment and embark on a new cycle, and (2 - o) become
Q-cells and in Model B will have an indefinite life-span. Since the cell population
is expanding, both parts ofthe diagram are bounded by exponential curves whose
exponent is determined by the doubling time (Td) of the whole population. The
age distributions of P- and Q-cells respectively are proportional to
N (t) = ae-bt (i)
Nq(t) (2 - a)e-bt (ii)
where
b log 2 log a (iii)
Td Tc
WVhen there is no cell loss it can be shown also that the fraction ofcells proliferating
is given by
p 1 (iv)
In the case of a cell population having a spread in cycle time (and in lengths of
the component phases) the phase boundaries in the diagram for P-cells are not
vertical but are as shown in the lower halfofFig. 9 (Barrett, 1966a).
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FIG. 9. Age distribution diagrams calculated for the BICR/A2 tumour. The upper diagram
is obtained by ignoring spread in cell cycle time; the lower diagram is the corresponding
curve when spread is taken into account.
Analysis o the continuous labelling curve.
The method of analysis was to assume the distribution of cell cvcle times
obtained from the labelled mitoses data, to draw the corresponding age distribution
diagrams first for Model A and then for Model B with selected values for the
constant of, and for each of these to calculate a continuous labelling curve, seeking
one which would fit the experimental data closely. In these calculations, it was
first assumed that the spread in G2 would have a negligible effect on the continuous
labelling curve and could therefore be assumed to be zero. This assumption is
reasonable, since its effect is only on curvature, and then only over the first 3
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or 4 hours of continuous labelling. When this assumption is made, the labelling
index under continuous labelling first increases until at the end of the G2 period it
is given by the fractional area of the age distribution diagram occupied by cells
in the S and G2 periods. Thereafter, labelled cells begin to appear at the beginning
of the diagram and the boundary between labelled and unlabelled cells (a vertical
line) sweeps through the G1 compartment until all P-cells are labelled. At the
same time (on Model B) the vertical line sweeps through the Q-cell compartment
also and at any point the labelling index may be calculated by determining the
appropriate fractional area.
In the case of the BICR/Ml tumour, calculation on the basis of Model A gives
a reasonable fit for the first 12 hours but thereafter the theoretical curve reaches
100% much too quickly. The curve in Fig. 6 is calculated on Model B for
o- 1-95, i.e., on the assumption that the Proliferative Fraction was 950/ (in
principle, when T, and Td are known, ox is specified by equations (iii) and (iv)
above, but in fact a value of c= 1-95 is entirely consistent with the measured
values of TC. and Td for BICR/M1). One is not justified in moving on to Model C
in this case; the experimental results are satisfactorily explained by a model in
which the distribution of cycle times is that given in Fig. 8 and in which there are
about 500 non-proliferating cells. Although the limits of error on this figure are
fairly large it is nevertheless clear that their proportion could not be more than
about 10%.
In the case of the BICR/A2 tumour, Model A gives an impossible result, since
it predicts almost 100% labelling at 70 hours. Fig. 7 shows the theoretical
curve (a) calculated on Model B, of being given by equation (iii) above as 1*26
(Proliferative Fraction of 26%). This curve is in satisfactory agreement with the
initial labelling index and the experimental points out to 36 hours, but thereafter
it does not rise sufficiently quickly.
We have examined two alternative explanations of this discrepancy: first
that it results from the presence within the tumour of cells with long cycle times,
cells which form an extended " tail " on the cycle time distribution and whiclh in
our analysis have been included in the Q-cell compartment; secondly, that the
discrepancy is due to cell loss from the tumour. As regards the first of these
possibilities, it is probably true that the firm distinction which we have made in
the definition of Model B between P-cells and Q-cells is an over-simplification of
the actual situation. It is also true that the presence of cells with cycle times in
the region of 100 hours would help to raise the theoretical continuous labelling
curve at later intervals. It is difficult, however, to see how this factor could
completely resolve the discrepancy. In Fig. 7 the discrepancy in labelling index
at 100 hours amounts to 20% of all cells. To resolve this, a number of Q-cells
equal to at least 20% of the whole cell population would have to be assumed
proliferative and since only those cells which label before 100 hours would affect
discrepancy, their cycle times could not be much in excess of this time. The
Proliferative Fraction as already found is, however, 26% and hence this assump-
tion involves almost doubling the Proliferative Fraction by cells having up to
twice the mean cycle time. The difficulty of assuming such a model is that the
corresponding labelled mitoses curve would differ considerably from that whiclh
has so far been computed. Despite the fact that the labelled mitoses data for
BICR/A2 show relatively large scatter. they nevertheless eliminate the possibilitv
that the " tail " ofthe cell cycle time distribution could be so large as to double the
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proportion of proliferative cells, hence it would seem that this explanation can
only partly resolve the discrepancy.
On the other hand, there is no doubt that the assumption of some degree of
cell loss could explain the observed discrepancy. Since what is required here is a
steepening of the curve with minimum effect on the early points, cell loss of type
(i) (see definition ofModel C above) might seem to be the best choice. By contrast
the other two types ofcell loss involve the loss ofsome labelled cells after relatively
short intervals. Fig. 7 shows the effect of assuming that Q-cells have a limited
life-span either of 1 or 1- times the tumour doubling time (190 or 285 hours)
the corresponding Proliferative Fractions are 3900 and 33% respectively. These
assumptions, which do improve the fit to the experimental points, imply that
respectively 18 or 12 cells were lost for every 100 produced at mitosis.
Comparing these two explanations for the observed discrepancy between the
theoretical and experimental continuous labelling curves, it would seem likely
that both may contribute to some extent. It is difficult to avoid the conclusion
that some cell loss was taking place from the BICR/A2 tumour, but its extent is
difficult to assess because the importance of an extended tail on the cycle time
distribution cannot be judged from the present data.
CONCLUSIONS
The two tumours examined in the present investigation had volume doubling
times which differed by a factor of just over 8. This factor was not, however,
reflected in a similar difference in mean cycle time. If the assumption is correct,
as seems to be borne out by the tritiated thymidine results, that the cell popula-
tions behaved in each case as though they consisted of two groups of cells, one
group proliferating with a specified distribution of cell cycle times and the other
group non-proliferating, then the mean cell cycle times seem to be in the ratio of
2-6: 1. The difference in growth rate is therefore largely the result of the propor-
tion ofproliferating cells being about 95 o in the case ofBICR/MI and only about
30%o in the case of BICR/A2.
The results have also enabled some, though rather imprecise, estimates to be
made of the degree of cell loss from the two tumours. BICR/M1, the more
rapidly proliferating, which had been maintained by repeated transplantation for
10 years. had no detectable cell loss; for BICR/A2, which was only in its 4th
transplant, the loss of up to 20 cells for every 100 produced at mitosis, wouild be
consistent with the data.
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